Novel Agents and Combinations in Hodgkin Lymphoma
0 vistas
• 07/09/23
0
0
Empotrar
administrator
Suscriptores
Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.
For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios